Division Laboratories

Attardi Lab
Academic Profile
Phone: (650) 725-8424
Fax: (650) 723-7382
E-mail: attardi@stanford.edu

Research Emphasis
Defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches.

Giaccia Lab
Academic Profile
Phone: (650) 723-7366
Fax: (650) 723-7382
E-mail: giaccia@stanford.edu
Administrative Associate: Sharon Clarke
Phone: (650) 723-7311
E-mail: sclarke@stanford.edu

Research Emphasis
Cellular response to hypoxia and ionizing radiation; cell-cycle control, apoptosis and angiogenesis in transformed cells

Malhotra Lab
Academic Profile
Phone: (650) 736-9231
Fax: (650) 723-7254
E-mail: smalhotra@stanford.edu
Clinical Research Assistant: Melissa Wong
Phone: (650) 736-4757
E-mail: measw93@stanford.edu

Research Emphasis
The design and discovery of small molecules that can be used as probes to understand protein-protein interactions and modulation of signal transduction pathways.

Rankin Lab
Academic Profile
Phone: (650) 497-8742
Fax: (650) 723-7254
E-mail: erankin@stanford.edu

Research Emphasis
The role of hypoxia-inducible factors in tumorigenesis.

Ye Lab
Academic Profile
Phone: (650) 497-8742
Fax: (650) 723-7254
E-mail: yej1@stanford.edu

Research Emphasis
Metabolic reprogramming in cancer.

Affiliated Laboratories

Lab Department Research Emphasis
Graves Radiation Oncology Applications of emerging functional and molecular imaging techniques in radiation therapy of cancer. More
Knox Radiation Oncology Bcl-2, Apoptotic signaling pathways (membrane and mitochondrial-mediated events), Development of novel therapeutic strategies to sensitize tumor cells to cytotoxic therapies, Cox-2, NF-kB, Anti-angiogenesis therapies   More
Koong Radiation Oncology Mechanisms of gene transcription and protein translation under hypoxic conditions
Le Radiation Oncology Identification of serum markers for tumor hypoxia and for prognosis in patients with head and neck or lung cancers
Loo Radiation Oncology Radiation treatment of lung cancer and head & neck cancers. 4-D multimodality imaging of tumor and organ motion using CT, PET, and MR; novel functional/metabolic imaging of tumor hypoxia.
Pratx Radiation Oncology Imaging of radionuclides with single-cell resolution, x-ray molecular imaging and high-performance medical computing.
Xing Radiation Oncology Image-guided intervention, MR spectroscopic imaging (MRSI) and radionuclide imaging (PET/CT, SPECT/CT), biologically conformable radiation threapy (BCRT), intensity modulated radiation therapy (IMRT), application of molecular imaging to radiation oncology.